Cantel: Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600
NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P...
Read full article »
President & CEO
George L. Fotiades
Cantel Medical is a medical device firm that manufactures and supplies infection section and prevention products to the healthcare sector.
Read more